CHICAGO (Reuters) - Two Iowa egg farms linked to a salmonella outbreak that has sickened thousands failed to follow their own safety plans, allowing rodents and other animals into poultry houses, U.S. Food and Drug Administration inspectors found.
NEW YORK (Reuters Health) - In a small study, people who had chronic pain as a result of damage to the nervous system reported feeling less pain, as well as less depression and anxiety, when they smoked marijuana compared to when they smoked a drug-free placebo.
WASHINGTON (Reuters) - U.S. health officials are set to rule on whether a faster-growing, genetically engineered fish is safe to eat in a decision that could deliver the first altered animal food to consumers’ dinner plates.
CHICAGO (Reuters) - A Purdue University food scientist using infrared spectroscopy took only an hour to find harmful E. coli bacteria in ground beef, a discovery that could cut days off investigations of outbreaks, the university said in a statement on Monday.
PARIS/BOSTON (Reuters) - Biotech company Genzyme Inc rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA on Monday, setting the stage for a protracted and potentially hostile takeover battle.
PHILADELPHIA/PARIS (Reuters) - France’s Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme Corp in a bid to rouse shareholders after failing to engage the U.S. biotechnology company in merger talks.
LONDON (Reuters) - An international scientific team has identified for the first time a genetic risk factor associated with common migraines and say their research could open the way for new treatments to prevent migraine attacks.
STOCKHOLM (Reuters) - Giving patients with a history of heart attacks a margarine enriched with omega-3 oils in addition to standard drugs appears to make no difference to their chances of having a repeat attack.
STOCKHOLM (Reuters) - Gene testing is shaping up to be a marketing battleground for new blood thinners like AstraZeneca’s Brilinta, underscoring the power and limitations of genetics as a tool to predict medical outcomes.
STOCKHOLM (Reuters) - Patients with chronic heart failure given injections of their own bone marrow stem cells have better heart function and live longer, German researchers said Sunday.